Monday, November 13, 2017

Ajinomoto Acquires Cambrooke Therapeutics

Cambrooke Therapeutics, Inc. (Cambrooke), an innovator in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announced it has been acquired by Ajinomoto Co. Inc. (Ajinomoto), a worldwide leader in amino acids, pharmaceuticals, high-quality seasonings, processed foods, beverages, and specialty chemicals, through its subsidiary Ajinomoto North America, Inc. Prior to the acquisition, Cambrooke was a privately-held business led by investors Galen Partners and Seventure Partners.

from Subscribe to Preparedfoods.com's RSS Feed http://ift.tt/2zzKmoQ
via IFTTT

No comments:

Post a Comment